Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical
and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection,
diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments
in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches;
drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies;
multimodality therapy; and integration of various approaches.
Benefits to authors We also provide many author benefits,
such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information
on our http://www.elsevier.com/authors/author-servicesauthor services.
Please see our https://www.elsevier.com/journals/clinical-genitourinary-cancer/\
1558-7673/guide-for-authorsGuide for Authors for information on article submission. If you require any further
information or help, please visit our http://service.elsevier.com/app/home/supporthub/publishing/Support Center
https://www.uk.elsevierhealth.com/clinical-genitourinary-cancer-15587673.html104152Clinical Genitourinary Cancerhttps://www.uk.elsevierhealth.com/media/catalog/product/1/5/15587673_7.jpg00GBPInStock/Revues28526128204 <IT>Clinical Genitourinary Cancer</IT> is a peer-reviewed journal that publishes original articles describing various aspects of clinical
and translational research in <B>genitourinary cancers</B>. <IT>Clinical Genitourinary Cancer</IT> is devoted to articles on <B>detection</B>,
<B>diagnosis</B>, <B>prevention</B>, and <B>treatment</B> of genitourinary cancers. The main emphasis is on recent scientific developments
in all areas related to <B>genitourinary malignancies</B>. Specific areas of interest include clinical research and mechanistic approaches;
drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies;
multimodality therapy; and integration of various approaches. <P><B>Benefits to authors</B><BR> We also provide many author benefits,
such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information
on our <URL><HREF>http://www.elsevier.com/authors/author-services</HREF><HTXT>author services</HTXT></URL>. <P>Please see our <URL><HREF>https://www.elsevier.com/journals/clinical-genitourinary-cancer/\
1558-7673/guide-for-authors</HREF><HTXT>Guide for Authors</HTXT></URL> for information on article submission. If you require any further
information or help, please visit our <URL><HREF>http://service.elsevier.com/app/home/supporthub/publishing/</HREF><HTXT>Support Center</HTXT></URL>
00104151Clinical Genitourinary Cancer00https://www.uk.elsevierhealth.com/media/catalog/product/https://www.uk.elsevierhealth.com/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.pngInStockDomestic1 YearIndividual1558-7673JOURNALELSEVIERIN STOCK1558-7673Volume 17journalsJournalsNoNoNoNoPlease SelectPlease SelectPlease Select
